EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

IL-17B Inhibits Hepatocellular Carcinoma Cell Proliferation

Joanna Pastwińska, Iwona Karwaciak, Kaja Karaś, Daria Grabarczyk, Anna Sałkowska, Marcin Ratajewski

Archivum Immunologiae et Therapiae Experimentalis · 01.01.2025 · 73 (1)

DOI: 10.2478/aite-2025-0020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archivum Immunologiae et Therapiae Experimentalis, online erschienen am 17.06.2025. Verfasst von Joanna Pastwińska und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Epigenetics, Institute of Medical Biology, Polish Academy of Sciences, Lodowa 106, 93-232 Lodz, Poland. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Interleukin-17, Receptors, Interleukin-17. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

IL-17RB is a cytokine receptor that binds interleukin (IL)-17B and IL-17E. While analyzing IL-17RB expression in various cancer cell lines, we found that this receptor is highly expressed at both the mRNA and protein levels in hepatocellular carcinoma (HCC) cells. This finding prompted us to investigate the effects of its ligand, IL-17B, on the proliferation of these cells. Our results demonstrate that IL-17B inhibits the proliferation of HCC cells through an AKT-dependent, but NF-κB-independent, mechanism. Additionally, IL-17B affected colony formation in these cells. Interestingly, these effects were not observed in melanoma cells, which express low levels of IL-17RB. Our results may represent a promising new approach for treating HCC – a disease for which immunological therapies have recently gained significant attention – especially considering that HCC patients experience progressive liver dysfunction and that the IL-17B–IL-17RB signaling pathway plays a role in liver regeneration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsInterleukin-17Receptors, Interleukin-17HumansCell ProliferationCell Line, TumorSignal TransductionNF-kappa BProto-Oncogene Proteins c-aktGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

Hepatocellular carcinomaIL-17BIL-17RBProliferation

Substanzen

Interleukin-17Receptors, Interleukin-17NF-kappa BProto-Oncogene Proteins c-aktIL17RB protein, human

Autor:innen und Institutionen

  • Laboratory of Epigenetics, Institute of Medical Biology, Polish Academy of Sciences, Lodowa 106, 93-232 Lodz, Poland.

Zitieren

APA

Pastwińska, J., Karwaciak, I., Karaś, K., Grabarczyk, D., Sałkowska, A., & Ratajewski, M. (2025). IL-17B Inhibits Hepatocellular Carcinoma Cell Proliferation. Archivum Immunologiae et Therapiae Experimentalis, 73(1). https://doi.org/10.2478/aite-2025-0020

Vancouver

Pastwińska J, Karwaciak I, Karaś K, Grabarczyk D, Sałkowska A, Ratajewski M. IL-17B Inhibits Hepatocellular Carcinoma Cell Proliferation. Archivum Immunologiae et Therapiae Experimentalis. 2025;73(1). doi:10.2478/aite-2025-0020

BibTeX
@article{Pastwiska2025,
  author = {Pastwińska, Joanna and Karwaciak, Iwona and Karaś, Kaja and Grabarczyk, Daria and Sałkowska, Anna and Ratajewski, Marcin},
  title = {IL-17B Inhibits Hepatocellular Carcinoma Cell Proliferation},
  journal = {Archivum Immunologiae et Therapiae Experimentalis},
  year = {2025},
  volume = {73},
  number = {1},
  doi = {10.2478/aite-2025-0020}
}
Kostenlos starten →